🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
Phase IIIb, randomized, multicenter, double-blind, prospective study to eva...
Status
Completed
Location
Centro de Investigación y Avances Médicos Especializados
Start Date
2023-03-21
Trial ID
NCT04841096
This superiority of central pressure versus peripheral measures to predict ...
Status
Unknown
Location
Hospital Nuestra Señora de la Esperanza
Start Date
2016-12-13
Trial ID
NCT02919059
Treatments Being Tested
This study will evaluate the efficacy and tolerability of saxagliptin compa...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT01006603
Treatments Being Tested
The process of atherosclerosis is multifactorial and involves many mechanis...
Status
Withdrawn
Location
Hospital Clínico San Carlos
Start Date
2012-05
Trial ID
NCT01593137
Treatments Being Tested
The purpose of the study is to determine the effect of glimepiride on dapag...
Status
Completed
Location
Local Institution
Start Date
2008-05
Trial ID
NCT00562250
Treatments Being Tested
Patients with type 2 diabetes mellitus are exposed to an excessive heart fa...
Status
Terminated
Location
Hannover Medical School
Start Date
2016-04-27
Trial ID
NCT02728453
Treatments Being Tested
This is a an open-label, randomized, single dose, four-way crossover, multi...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-09-27
Trial ID
NCT01725672
Treatments Being Tested
The purpose of this study is to compare the efficacy of Amaryl®M 1/500 mg t...
Status
Completed
Location
HeeYoung Lee
Start Date
2009-05
Trial ID
NCT00913367
The study purpose is to assess adverse events in patients with Type 2 diabe...
Status
Terminated
Location
Local Institution
Start Date
2013-10
Trial ID
NCT01944618
Treatments Being Tested